SAHPRA issues warning on the rise of sales of counterfeit Ozempic
Zuko Komisa Ozempic and other fake Glucagon-like Peptide (GLP-1) items are becoming more and more common on the local market, which has alarmed the South African Health items Regulatory Authority (SAHPRA). A rise in suspected counterfeit Ozempic, also known as semaglutide, a registered medicine from Novo Nordisk that contains GLP-1 … Continue reading SAHPRA issues warning on the rise of sales of counterfeit Ozempic
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed